Digital Health Start-Ups Continue To Be Attractive SPAC Targets
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
You may also be interested in...
With the acquisition of Lemonaid Health, at-home genome testing company 23andMe hopes to transform the primary care business with genetics insights.
Investors have been wary of LuminaraDX since its placement on NASDAQ, driving the share price down.
For life sciences investors, the past year has been the busiest period in recent memory, say Goodwin partners Sophie McGrath and David Mardle. But what are the industry's drivers and key investor trends in 2021?